Evidence brief on facilitators, barriers and hesitancy of COVID-19 booster doses in Canada.

Autor:	Young KM; National Microbiology Laboratory, Public Health Agency of Canada, GuelphON., Corrin T; National Microbiology Laboratory, Public Health Agency of Canada, GuelphON., Pussegoda K; National Microbiology Laboratory, Public Health Agency of Canada, GuelphON., Baumeister A; National Microbiology Laboratory, Public Health Agency of Canada, GuelphON., Waddell LA; National Microbiology Laboratory, Public Health Agency of Canada, GuelphON.
Jazyk:	angličtina
Zdroj:	Canada communicable disease report = Releve des maladies transmissibles au Canada [Can Commun Dis Rep] 2024 Oct 03; Vol. 50 (10), pp. 338-344. Date of Electronic Publication: 2024 Oct 03 (Print Publication: 2024).
DOI:	10.14745/ccdr.v50i10a02
Abstrakt:	Background: Understanding the facilitators, barriers and hesitancy to accepting COVID-19 booster doses is important for encouraging recommended vaccination. This evidence brief summarizes literature on the intention to accept or reject COVID-19 vaccine booster doses and the factors associated with intention/uptake among individuals in Canada. Methods: A database of COVID-19 literature established at the Public Health Agency of Canada was searched for articles referencing vaccination and knowledge, attitudes and behaviours towards COVID-19 boosters. A grey literature search of Canadian governmental and academic institutions was also conducted. Primary research conducted in Canada (n=21) and relevant systematic reviews of the global literature (n=8) were included in this evidence brief. Results: Intentions to get a booster dose in the general population have decreased between 2021-2023, with intentions varying across subpopulations. In Canada and within the global systematic reviews, facilitators, barriers and hesitancy were similar. Older age was the most common factor positively associated with intention/uptake of a booster, and the most common motivators were government/healthcare provider recommendations and helping to protect others. The main reasons for hesitancy were concerns about vaccine side effects and a lack of belief in the vaccine's efficacy. Conclusion: Intentions to get a booster dose have decreased in Canada. Understanding the reasons for vaccine hesitancy and motivators for obtaining a booster can help guide future public health COVID-19 booster vaccination programs. Competing Interests: Competing interests None.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu